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1. Introduction 
Ethyl&carboline-3-carboxylate (P-CCE) has been 
isolated from brain and urine extracts and found to 
potently inhibit the binding of [3H]benzodiazepines 
to specific receptor sites in the brain [ 11. Although 
/3-CCE (or a closely related derivative) was initially 
postulated to be an endogenous ligand of the benzo- 
diazepine receptor [ 11, subsequent studies strongly 
suggest [2] that this compound (as well as its methyl 
ester and 3-carboxylic acid derivatives) is formed 
artifactually during the extraction and isolation pro- 
cedures. 
Nonetheless, the extremely high affinity of @-CCE 
and related compounds in displacing [3H]benzodia- 
zepines from receptor sites in the central nervous sys- 
tem [3,4] coupled with recent reports that P-CCE and 
related /3-carbolines are specific antagonists of many 
of the pharmacologic actions of benzodiazepines [S- 
91, suggests that these compounds may be valuable 
tools for studying the regulation of the benzodiazepine 
receptor. 
cimol) markedly enhanced the apparent affinity of 
[3H]benzodiazepines for the benzodiazepine receptor 
[ 111. These observations prompted us to examine the 
effect of other drugs and anions known to enhance 
the apparent affinity of [3H]benzodiazepines for 
benzodiazepine receptors on the binding of /3-[3H]- 
CCE. We now report that in contrast to the changes 
in affinity of [ 3H] benzodiazepines elicited by halide 
ions [ 121, barbiturates [ 13- 151, and pyrazolopyridines 
[16,17], the apparent affinity of p-[3H]CCE is unaf- 
fected by these agents. Furthermore, Scatchard ana- 
lysis of /3-[3H]CCE binding to cerebral cortical and 
cerebellar membranes revealed a significantly greater 
number of binding sites than was observed with either 
[3H]diazepam or [3H]flunitrazepam, suggesting that 
at low concentrations benzodiazepines selectively 
label a subpopulation of the receptors labelled with 
fl- [3H] CCE. Alternatively, p- [ 3H] CCE may bind to 
sites that are distinct from those labelled with [3H]- 
benzodiazepines. 
It was suggested [3,10] that there may be signifi- 
cant differences in the regulation of the benzodiaze- 
pine receptor when it is occupied by an ‘antagonist’ 
such as fi-CCE, rather than an ‘agonist’ (e.g., diazepam). 
In [3 ,101 binding of /3- [3H] carbolines was enhanced 
only slightly or not at all by y-aminobutyric acid 
(GABA). In contrast, under similar experimental con- 
ditions, GABA and GABA-mimetic agents (e.g., mus- 
2. Materials and methods 
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Adult, male Sprague-Dawley rats (Taconic Farms, 
Germantown NY) were killed by decapitation. Osmo- 
tically shocked membrane fragments were prepared 
from cerebral cortex (pooled parietal, temporal, 
occiptal and frontal cortices) or cerebellum by dis- 
ruption with a Polytron (Brinkmann Instruments, 
setting 6, 1.5 s) in 100 vol. potassium phosphate buffer 
(50 mM, pH 7.4). The tissue was centrifuged at 
20 000 X g for 20 min and reconstituted in an equal 
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volume of 
a total of 5 times, and reconstituted following 
the final in 60 vol. homogenization 
buffer. Incubation conditions and methodology for 
the determination of [ 3H] benzodiazepine or p- [3H]- 
CCE binding were performed essentially as in [ 181 in 
a total volume of 1.5 ml. In experiments comparing 
either the kinetic properties of [ 3H] benzodiazepines 
and fl-CCE or the effects of drugs on the binding of 
these radioligands, aliquots of the same tissue sample 
were used. 
Specific binding was defined as the difference 
between binding in the absence (total binding) and 
presence (non-specific binding) of a large molar excess 
of non-radioactive diazepam (3 PM) or methyl-p-car- 
boline3-carboxylate @-CCM) (3 /rM). No statistically 
significant differences in the non-specific binding of 
either radioligand were observed when either diazepam 
or P-CCM were used to determine the levels of non- 
specific binding (e.g., [ 3H] diazepam + /3-CCM = [ 3H]- 
diazepam + diazepam). The ratio of specific to non- 
specific binding was, however, consistently lower 
when fl-CCE was used as a l&and compared with either 
[3H] diazepam or [ 3H] flunitrazepam. 
[3H]Diazepam (spec. act. 87.6 Ci/mmol)and [3H]- 
flunitrazepam (spec. act. 87.9 Ci/mmol) were pur- 
chased from New England Nuclear (Boston MA). 
/3- [3H] CCE (spec. act. 24 Ci/mmol) was obtained 
from Amersham (Arlington Heights IL). Diazepam 
was a gift of Hoffmann-LaRoche (Nutley NJ) and SQ 
65,396 was donated by Squibb Labs. (Princeton NJ). 
Methyl-/3-carboline-3-carboxylate and (+)-dimethyl- 
butylbarbituric acid [(+)-DMBB] were synthesized as 
in [9,14]. Sodium pentobarbital was purchased from 
Abbott Labs. (Chicago IL). All other materials were 
obtained from standard commercial sources. 
3. Results 
The binding of [3H]diazepam,at 0.88 nM (-0.1 K,, 
units) was significantly enhanced in the presence of 
20-1000 mM NaCl. The ECso (concentration required 
to elicit a half-maximum enhancement) for NaCl was 
estimated to be 30 mM. The enhancement of [3H]- 
diazepam binding by NaCl was a result of an increase 
in the apparent affinity of the radioligand for receptor 
(unpublished observations and [ 121) rather than a 
change in receptor number. In contrast, NaCl did not 
significantly enhance /3- [3H] CCE binding over I- 1000 
mM (fig.1). The barbiturates pentobarbital and (+)- 
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Fig.1. Effect of chloride on p-[3H]CCE and [3H]diazepam 
binding. The effect of NaCl on the binding of /3-[3H]CCE 
(A) and [‘HI diazepam (0) was studied in cerebral cortical 
membranes, washed 5 times in 100 vol. potassium phosphate 
buffer (pH 7.4) as in section 2. Values represent the % increase 
in binding compared to chloride-free incubations and are 
taken from a representative experiment. The experiment was 
repeated 3 times with identical results. Experiments were 
done with p-[3H]CCE and [3H]diazepam at -0.1 Kd units, 
0.1 nM and 0.88 nM, respectively. 
DMBB and the pyrazolopyridine SQ 65,396, signifi- 
cantly enhanced [3H]diazepam binding in a NaCl- 
enriched buffer with EC50 values of45,36 and 0.28 PM, 
respectively. In contrast, these drugs did not elicit a 
statistically significant increase in the binding of 
p-[3H] CCE (fig.2). The effects of pentobarbital 
240, 
Fig.2. Effects of barbiturates and pyrazolopyridines on 
flj3H]CCE binding. In contrast to [‘Hldiazepam binding 
(closed symbols), no statistically significant enhancements 
were observed for drugs on p-[ 3H]CCE binding (open sym- 
bols): (0,~) SQ 65,396; (o,o) sodium pentobarbital; (a,~) 
(+)-DMBB. Assay conditions were identical to those in fig.1, 
except for the addition of 150 mM NaCl to the incubations 
in order to optimize the effects of barbiturates and SQ 65,396. 
Values represent the % increase over ‘no-drug’ control incuba- 
tions and are taken from a typical experiment, which was 
repeated at least 3 times with similar results. 
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Fig.3. Scatchard analysis of P-[3H]CCE and [‘Hldiazepam 
binding. (A) Scatchard analysis of [‘HI diazepam (o) and 
/3-[3H]CCE (0) binding using cerebral cortical membranes 
washed 5 times. (B) Scatchard analysis comparing the binding 
of [ ‘Hldiazepam (0) and [3H]flunitrazepam (A) top-[ ‘H]CCE 
(0) in identically prepared cerebellar membranes. Assay con- 
ditions were as in section 2. Binding parameters are summar- 
ized in table 1. The binding capacity for @-(‘H]CCE was 
significantly greater than [ 3H] diazepam or [‘HI flunitrazepam 
in all experiments (see table 1). 
(500 m) were also examined on the binding of both 
fl-[3H]CCE (1 nM) and [3H]flunitrazepam (1 nM) at 
37°C in sodium phosphate buffer containing 150 mM 
NaCI. Under these conditions, the binding of p-[3H]- 
CCE was not enhanced while a significant increase in 
[jH]flunitrazepam binding (73%) was observed. The 
Kd of fl- [3H] CCE, like that of benzodiazepines [ 1’91 
was increased -7-fold at 37°C compared to incuba- 
tions done at 0-4°C (unpublished). 
The observation that GABA does not enhance (or 
enhances very weakly)/3- [3H] carboline binding [3 ,101 
suggests that the binding of a compound which is a 
functional benzodiazepine antagonist [5-91 differs 
substantially from the binding of a benzodiazepine to 
its recognition site. Since it is hypothesized that 
pyrazolopyridines, barbiturates, and Cl- increase the 
affinity of the benzodiazepine receptor at a distinct 
locus from GABA [ 13,23,24], we have examined the 
effects of agents which increase the apparent affinity 
of benzodiazepines at a chloride ionophore site (the 
‘barbiturate receptor’, cf. [15]) on p-[3H]CCE bind- 
ing. Our results clearly demonstrate that, in contrast 
to the binding of [3H]benzodiazepines, neither 
anesthetic nor convulsant barbiturates, pyrazolo- 
pyridines, nor anions alter the apparent affinity of 
the fl-carbolines. 
Scatchard analyses of the binding of /3-[3H]CCE, Perhaps the most interesting observation here is 
[3H] diazepam, and ]3H]flunitrazepam to cerebral the very significant differences in the number or sites 
cortical and cerebellar membranes (fig.3, table 1) ‘labelled’ by p-[3H]CCE compared with either [3H]- 
demonstrated that the maximum number of binding diazepam or [ 3H] flunitrazepam. In [3] no significant 
sites (B,,) observed with p- [3H] CCE is significantly difference in receptor number was observed using 
greater than the number of sites observed with either 
[3H] diazepam or [ 3H] flunitrazepam. The number of 
/3-[3H]CCE binding sites was almost 80% greater in 
the cerebellar membranes and 60% greater in cerebral 
cortical membranes (table 1) than were the number 
of [3H] diazepam binding sites. 
4. Discussion 
The benzodiazepine receptor has been proposed to 
be a component of a larger receptor complex consist- 
ing of recognition sites for benzodiazepines and GABA, 
which are functionally (if not physically) coupled to 
a Cl- channel [20-221. 
Table 1 
Binding of p-[ ‘H]CCE, [ ‘Hldiazepam and [ “Hlflunitrazepam in cerebral cortex and cerebellum 
(values represent he X * SEM of 3-4 expt) 
Cerebral cortex Cerebellum 
B d max Kde I B max Kd r 
P-[aH]CCE 2505 f 222 1.05 +_ 0.04 0.997 + 0.003 31785 96 1.09 f 0.3 0.983 f 0.01 
[ 3H] Diazepam 1396 f 14Sa 8.6 t 0.56 0.998 f 0.002 1939 f 175b 11.2 * 0.9 0.992 + 0.002 
[“HI Flunitrazepam 2075 + 371’ 3.7 + 0.6 0.994 f 0.002 
a P < 0.02; b P < 0.002; c P < 0.05 compared to B,,, of p-[ 3H]CCE binding (by Student’s r-test); d fmol/mg protein; e nM 
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[3H]propyl$-carboline-3-carboxylate and t3H] fluni- 
trazepam as ligands. Furthermore, it was concluded 
in [3] that the binding of these two ligands was mutu- 
ally exclusive. Differences in tissue preparation, buff- 
ers or radioligand could account for this discrepancy. 
However, the marked differences in B,, observed 
between p-[3H] CCE and [ 3H] benzodiazepines (80% 
in cerebral cortex; 60% in cerebellum) in our study 
suggest hat at low concentrations, the benzodiazepines 
may bind to a subpopulation of sites which are fully 
occupied by /3-[3H]CCE. Despite the high affinity of 
/3-CCE for benzodiazepine receptors (and vice versa), 
it could also be hypothesized that p-[3H]CCE binds 
to a distinct class of sites which benzodiazepines 
occupy only at very high concentrations. This hypoth- 
esis is supported by the observation that the non- 
specific binding of @[3H] CCE is very similar using 
either 3 PM diazepam or /3-CCM. These sites may 
represent a distinct ‘antagonist’ site with a pharma- 
cological profile similar to that of the ‘agonist’ site. 
In this regard, high affinity anti-estrogen binding sites 
that are distinct from the estrogen receptor itself have 
been reported [25]. 
The regulation of benzodiazepine receptors differs 
from other drug and neurotransmitter receptors in 
that rapid changes in receptor number can occur in 
vivo and in. vitro after drug treatment or physiological 
manipulation (cf. [26]). It is possible that the observed 
differences in site number between [3H]benzodiaze- 
pines and /3-t3H] CCE could be related to an ‘inducible’ 
population of cryptic binding sites that are labelled 
by /I- [ 3H] CCE. Subsequent investigations will undoubt- 
edly clarify the nature of the apparent differences in 
regulation and site number observed between benzo- 
diazepines and fl-CCE. 
References 
[I] Braestrup, C., Nielsen, M. and Olsen, C. (1980) Proc. 
Natl. Acad. Sci. USA 71,2288-2292. 
[2] Squires, R. (1981) in: CABA and Benzodiazepine 
Receptors (Costa, E. et al. eds) pp. 129-138, Raven, 
New York. 
131 
141 
151 
[61 
[71 
[81 
[91 
[lOI 
1111 
1121 
1131 
1141 
[I51 
[I61 
[I71 
[I81 
iI91 
WI 
Nielsen, M., Schou, H. and Braestrup, C. (1981) J. 
Neurochem. 36,276-285. 
Braestrup, C., Nielsen, M., Skovbjerg, H. and Gredal, D. 
(1981) in: GABA and Benzodiazepine Receptors (Costa, 
E. et al. eds) pp. 1477155, Raven, New York. 
Cowen, P., Green, A., Nutt, D. and Martin, 1. (1981) 
Nature 290,54-55. 
Oakley, N. and Jones, B. (1980) Eur. J. Pharmacol. 
68,381-382. 
Tenen, S. and Hirsch, J. (1980) Nature 288, 609-610. 
Skolnick, P., Paul, S., Crawley, J., Rice, K., Barker, S., 
Weber, R., Cain, M. and Cook, J. (1981) Eur. J. Phar- 
macol. 69,525527. 
Cain, M., Weber, R., Guzman, F., Cook, J., Barker, S., 
Rice, K., Crawley, J., Paul, S. and Skolnick, P. (1981) 
submitted. 
Ehlert, F., Roeske, S., Braestrup, C., Yamamura, S. 
and Yamamura, H. (1981) Eur. J. Pharmacol. 70, 
593-596. 
Tallman, J., Thomas, J. and Gallager, D. (1978) Nature 
214,383-385. 
Costa, T., Rodbard, D. and Pert, C. (1979) Nature 277, 
315-317. 
Skolnick, P., Rice, K., Barker, J. and Paul, S. (1981) 
Eur. J. Pharmacol. 65, 125-127. 
Skolnick, P., Rice, K., Barker, J. and Paul, S. (1981) 
Brain Res. in press. 
Leeb-Lundberg, F., Snowman, A. and Olsen, R. (1980) 
Proc. Natl. Acad. Sci. USA 71, 7468-7472. 
Beer, B., Klepner, C., Lippa, A. and Squires, R. (1978) 
Pharmacol. Biochem. Behav. 9, 8499851. 
Williams, M. and Risley, E. (1979) Life Sci. 24, 
833-842. 
Paul, S. and Skolnick, P. (1978) Science 202, 892-894. 
Speth, R., Wastek, G. and Yamamura, H. (1979) Life 
Sci. 24, 351-358. 
Paul, S., Marangos, P. and Skolnick, P. (1981) Biol. 
Psychiat. 16,213-229. 
[21] Olsen, R. and Leeb-Lundberg, L:. (1981) in: GABA and 
Benzodiazepine Receptors (Costa, E. et al. eds) pp. 
933102, Raven, New York. 
[22] Skolnick, P. and Paul, S. M. (1981) Annu. Rep. Med. 
Chem. in press. 
[23] Leeb-Lundberg, F., Snowman, A. and Olsen, R. (1981) 
J. Neurosci. 1,471-477. 
[24] Skolnick, P., Moncada, V., Barker, J. and Paul, S. 
(1981) Science 211, 1448-1450. 
[25] Sutherland, R. L., Murphy, L. C., Foo, M. S., Green, 
M. D., Whybourn, A. M. and Krozowski, Z. S. (1980) 
Nature 288, 273-275. 
1261 Skolnick, P. and Paul, S. M. (1981) Med. Res. Rev. 1, 
3-22. 
272 
